OTUD3 — OTU Deubiquitinase 3

OTUD3 — OTU Deubiquitinase 3

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">OTUD3 — OTU Deubiquitinase 3</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>OTUD3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>OTU Deubiquitinase 3</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/57567" target="_blank">57567</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167695" target="_blank">ENSG00000167695</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/607375" target="_blank">607375</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q5T7Q2" target="_blank">Q5T7Q2</a></td>
</tr>
<tr>
<td class="label">PARK Locus</td>
<td>PARK11</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td><a href="/diseases/parkinsons-disease">Parkinson's Disease</a></td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Heart, Kidney, Liver</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color

OTUD3 — OTU Deubiquitinase 3

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">OTUD3 — OTU Deubiquitinase 3</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>OTUD3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>OTU Deubiquitinase 3</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/57567" target="_blank">57567</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167695" target="_blank">ENSG00000167695</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/607375" target="_blank">607375</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q5T7Q2" target="_blank">Q5T7Q2</a></td>
</tr>
<tr>
<td class="label">PARK Locus</td>
<td>PARK11</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td><a href="/diseases/parkinsons-disease">Parkinson's Disease</a></td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Heart, Kidney, Liver</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

OTUD3 — OTU Deubiquitinase 3

Overview

OTUD3 (OTU Deubiquitinase 3), encoded by the OTUD3 gene on chromosome 17p13.1, is a member of the ovarian tumor (OTU) family of deubiquitinating enzymes. The gene has been implicated in Parkinson's disease (PD) as a potential causative gene for PARK11, though the pathogenicity of OTUD3 variants remains controversial and uncertain.

Introduction

OTUD3 was first linked to Parkinson's disease in 2014 when whole-exome sequencing studies identified rare variants in patients with familial PD[@yang2014][@shi2014]. However, subsequent studies have yielded conflicting results regarding the pathogenic nature of OTUD3 variants, and its role in PD pathogenesis remains uncertain compared to established PD genes like [LRRK2](/genes/lrrk2) or [SNCA](/genes/snca).

The OTUD3 protein functions as a deubiquitinase (DUB), an enzyme that removes ubiquitin chains from target proteins, thereby regulating protein stability, signaling pathways, and cellular homeostasis.

Structure

OTUD3 is a 524-amino acid protein with the following domain architecture:

OTU Domain (Residues 85-270)

The core catalytic domain shares homology with other OTU family deubiquitinases:

• Catalytic triad: Cys-His-Asp residues required for protease activity
• Ubiquitin-binding surface: Interacts with ubiquitin substrates
• zinc-finger motif: Stabilizes the domain structure

N-Terminal Region (Residues 1-84)

• Contains low-complexity sequences
• May mediate protein-protein interactions

C-Terminal Region (Residues 271-524)

• Regulatory functions
• Potential interaction motifs

Normal Function

Under physiological conditions, OTUD3 participates in several cellular processes:

Deubiquitination Activity

OTUD3 removes ubiquitin chains from target proteins:

• K48-linked chains: Typically target proteins for proteasomal degradation
• K63-linked chains: Regulate signaling complexes and endocytosis
• Linear chains: Regulate NF-κB signaling pathways

Cellular Pathways

• p53 pathway: OTUD3 can stabilize p53 by removing ubiquitination
• AKT signaling: Regulates AKT protein stability and signaling
• Cellular stress response: Involved in DNA damage repair
• Protein quality control: Maintains cellular proteostasis

Tissue Distribution

OTUD3 is expressed in multiple tissues:

• Brain: Neurons and glial cells
• Heart: Cardiac myocytes
• Kidney: Renal tubular cells
• Liver: Hepatocytes

Parkinson's Disease Association

Evidence for Pathogenic Role

The initial studies linking OTUD3 to PD reported:

Controversy and Uncertainties

Subsequent investigations have raised questions about OTUD3's pathogenicity:

Compared to established PD genes such as [LRRK2](/genes/lrrk2), [GBA](/genes/gba), or [SNCA](/genes/snca), OTUD3 remains a gene of uncertain significance in PD genetics.

Current Classification

• PARK11 status: Considered uncertain/controversial
• ACMG classification: Variants typically classified as variants of uncertain significance (VUS)
• Clinical utility: Not currently used for clinical testing

Therapeutic Implications

Given the uncertain pathogenicity of OTUD3 variants, therapeutic targeting remains speculative:

Potential Therapeutic Approaches

Research Directions

• Better understanding of OTUD3 substrate specificity
• Development of cellular and animal models
• Correlation with clinical phenotypes

Related Genes and Pathways

OTUD3 interacts with several PD-relevant pathways:

• [LRRK2](/genes/lrrk2): Both implicated in PD, though LRRK2 has stronger evidence
• [GBA](/genes/gba): Established PD gene involved in autophagy
• [SNCA](/genes/snca): Alpha-synuclein aggregation pathway
• [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system): Core pathway for protein clearance
• [Mitophagy](/mechanisms/mitophagy-pathway): Mitochondrial quality control

References